CompletedPhase 3NCT00628498
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Studying Hepatic veno-occlusive disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jazz Pharmaceuticals
- Principal Investigator
- William Tappe, M.D.Jazz Pharmaceuticals
- Intervention
- Defibrotide(drug)
- Enrollment
- 1206 target
- Eligibility
- All sexes
- Timeline
- 2007 – 2016
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Mayo Clinic Cancer Center, Phoenix, Arizona, United States
- Arizona Oncology, Scottsdale, Arizona, United States
- University Medical Center, Tucson, Arizona, United States
- University of Arkansas for Medical Services, Little Rock, Arkansas, United States
- City of Hope Medical Center, Duarte, California, United States
- The University of California, San Diego, La Jolla, California, United States
- Loma Linda University, Loma Linda, California, United States
- Long Beach Memorial Medical Center, Long Beach, California, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's Hospital & Research Center Oakland, Oakland, California, United States
- Children's Hospital of Orange County (CHOC), Orange, California, United States
- Sutter Institute for Medical Research, Sacramento, California, United States
- University of California Davis Health System, Sacramento, California, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00628498 on ClinicalTrials.govOther trials for Hepatic veno-occlusive disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05987124Defibrotide Dose-escalation for SOS Post-HSCTNew York Medical College
- RECRUITINGNCT06715046Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell TransplantationUniversity of Turin, Italy
- RECRUITINGNCT05090345A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).Duke University
- ACTIVE NOT RECRUITINGNANCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction SyndromeChildren's Mercy Hospital Kansas City